Estring

Estring is a vaginal ring designed for localized estrogen therapy. It contains estradiol hemihydrate and is used for conditions related to menopause. This product is manufactured by Pfizer Oy in the EU.

Estring is primarily used for vaginal atrophy and symptoms of menopause, such as dryness and discomfort. It delivers a low dose of estradiol directly to the vaginal tissue, which may help alleviate these symptoms. The ring is inserted into the vagina and remains in place for a specified period, providing continuous release of the hormone.

Common effects of using Estring may include localized irritation, vaginal discharge, or mild discomfort. Some users might experience breast tenderness or changes in menstrual bleeding patterns. These effects are generally mild and temporary, but persistent issues should be discussed with a healthcare provider.

Estring should be handled with clean hands to avoid infection. It is important to follow the prescribed duration of use and not to remove the ring prematurely. Users with a history of estrogen-sensitive conditions should consult a healthcare provider before use. Regular check-ups are recommended to monitor the effects and safety of the treatment.

Estring may interact with certain medications, including those that affect liver enzymes. It is advisable to inform a healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and other substances that affect liver function might also influence the effectiveness of Estring.